A multi-million dollar Super Bowl ad from telehealth company Hims and Hers downplays risks and side effects of compounded ...

Telehealth company's spot decries medications from others as "priced for profits, not patients," while its own weight-loss drugs are "affordable." ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $30.51 which represents a decrease of $-0.36 or -1.17% from the prior close of $30.87. The stock opened at $29.28 and touched a low ...

Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the ...

The company called 2024 a "breakthrough" year as it launched multiyear transformation program and rewired the business into three segments. The low-cost carrier reported its fourth-quarter results ...

Hims & Hers, a tele-health start-up, aims to stand apart from dozens of Super Bowl commercials hawking snacks with a spot ...

Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced ...

The Super Bowl spot is part of a larger campaign as Hims & Hers continues to highlight its weight loss treatments. The ad ...

Hims & Hers Health (NYSE: HIMS) is a relatively young company addressing age-old healthcare challenges by offering ...

Hot takes have been flying about why HubSpot's organic traffic declined. Here are perspectives from ex-employees.

Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.